MELBOURNE, Australia--(BUSINESS WIRE)--Genetic Technologies Limited (NASDAQ:GENE) (ASX:GTG) is pleased to report it has released its Appendix 4E - Preliminary Final Report, for the year ended 30 June 2007, to the Australian Securities Exchange. The 62-page document will be filed under a Form 6-K with the US Securities and Exchange Commission shortly.
